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Background: This study aimed to investigate the recent prevalence, management, and comorbidities of diabetes among Korean 
adults aged ≥30 years by analyzing nationally representative data. 
Methods: This study used data from the Korea National Health and Nutrition Examination Survey from 2016 to 2018, and the 
percentage and total number of people ≥30 years of age with diabetes and impaired fasting glucose (IFG) were estimated.
Results: In 2018, 13.8% of Korean adults aged ≥30 years had diabetes, and adults aged ≥65 years showed a prevalence rate of 
28%. The prevalence of IFG was 26.9% in adults aged ≥30 years. From 2016 to 2018, 35% of the subjects with diabetes were not 
aware of their condition. Regarding comorbidities, 53.2% and 61.3% were obese and hypertensive, respectively, and 72% had hy-
percholesterolemia as defined by low-density lipoprotein cholesterol (LDL-C) ≥100 mg/dL in people with diabetes. Of the sub-
jects with diabetes, 43.7% had both hypertension and hypercholesterolemia. With regard to glycemic control, only 28.3% reached 
the target level of <6.5%. Moreover, only 11.5% of subjects with diabetes met all three targets of glycosylated hemoglobin, blood 
pressure, and LDL-C. The percentage of energy intake from carbohydrates was higher in diabetes patients than in those without 
diabetes, while that from protein and fat was lower in subjects with diabetes.
Jung CH, et al.
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INTRODUCTION
Over the past few decades, the prevalence of diabetes has 
steadily increased [1-3]. Globally, 425 million people, repre-
senting 8.8% of the global adult population (20 to 79 years) in 
2017 and 463 million (9.3%) in 2019, are estimated to be living 
with diabetes according to the International Diabetes Federa-
tion (IDF) Diabetes Atlas [1]. The global prevalence of diabetes 
has nearly doubled since 1980, rising from 4.7% to 9.3% in the 
adult population [2,3]. In addition, of the 463 million people 
living with diabetes, half (50.1%) are unaware of their condi-
tion [1].
A high burden of diabetes complications as well as diabetes 
itself have a significant impact on population health. Diabetes 
was the eighth leading cause of death among both sexes and 
the fifth leading cause of death in women in 2012 globally [4]. 
In Korea, diabetes was the sixth leading cause of death among 
both sexes [5]. In particular, age-standardized mortality due to 
diabetes was higher in Korea than in other countries that are 
part of the Organisation for Economic Co-operation and De-
velopment (OECD) [6]. Therefore, there is an urgent need to 
implement interventions that prevent diabetes, enhance its 
early detection, and promote lifestyle modifications and ag-
gressive medical treatment to prevent or delay complications. 
In addition, valid and consistent estimates of diabetes preva-
lence are needed to evaluate the effect of interventions, com-
pare trends over time, and estimate reaching diabetes targets.
Since 2012, the Korean Diabetes Association (KDA) has 
published Diabetes Fact Sheets (DFS) based on the Korea Na-
tional Health and Nutrition Examination Survey (KNHANES), 
a nationwide survey conducted by the Korean Centers for Dis-
ease Control and Prevention (KCDC). The purpose of this DFS 
is to provide national representative statistics on the prevalence 
and numbers of diabetes and impaired fasting glucose (IFG) 
and the management status of diabetes and its comorbidities in 
Korea. The objective of this study was to investigate the preva-
lence, total number, management, and comorbidities of diabe-
tes among Korean adults ≥30 years by analyzing nationally 
representative KNHANES data. In addition, energy intake and 
percentage of energy intake from each macronutrient were in-
vestigated among those with diabetes, previously diagnosed di-
abetes, and those without diabetes.
METHODS
Study population
This study analyzed data from KNHANES VII (2016 to 2018). 
KNHANES is a population-based cross-sectional survey that 
employs a rolling sampling design involving a stratified, multi-
stage, probability cluster survey of a representative sample of 
the Korean population [7,8]. It consists of three surveys: a health 
interview survey, a health examination survey, and a nutrition 
survey. The total number of subjects ≥30 years of age with dia-
betes and IFG were determined based on the National Popula-
tion Census in 2018. We constructed two datasets from KNHANES 
as follows: (1) KNHANES 2018 and (2) KNHANES 2016 to 
2018 (merged 3 years of data). Data from KNHANES 2018 
were used to calculate the prevalence of diabetes and IFG. Data 
for KNHANES 2016 to 2018 (merged 3 years of data) were used 
to identify the management status of diabetes and comorbidi-
ties in diabetes and energy intake.
Informed consent was obtained during the process of KNHANES, 
and this manuscript was approved by the Institutional Review 
Board of Soonchunhyang University Bucheon Hospital (IRB 
No. 2020-05-001).
Biochemical measurements
After overnight fasting, fasting plasma glucose (FPG), total 
cholesterol (TC), high-density lipoprotein cholesterol (HDL-
C), and triglyceride (TG) levels were measured using a Hitachi 
Autonomic Analyzer 7600 (Hitachi, Tokyo, Japan). Low-densi-
ty lipoprotein cholesterol (LDL-C) was measured by direct as-
say for persons with TG >200 mg/dL (Hitachi Automatic Ana-
lyzer 7600). Thus, we used either directly measured or calculat-
ed LDL-C according to the Friedewald formula: LDL-C=TC–
HDL-C–(TG/5) [9]. Glycosylated hemoglobin (HbA1c) levels 
Conclusion: The high prevalence and low control rate of diabetes and its comorbidities in Korean adults were confirmed. More 
stringent efforts are needed to improve the comprehensive management of diabetes to reduce diabetes-related morbidity and 
mortality.
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were measured using high-performance liquid chromatogra-
phy (HLC-723G7; Tosoh, Tokyo, Japan).
Definitions of IFG, diabetes, and its related comorbidities
The diagnosis of diabetes was based on FPG ≥126 mg/dL, cur-
rent use of anti-diabetic medication(s), a previous history of 
diabetes, or HbA1c ≥6.5% [10]. IFG was defined by FPG in 
the range of 100 to 125 mg/dL among those without diabetes 
[10]. The glycemic control rate in diabetes was defined as the 
rate of people with HbA1c <6.5% among people with diabetes 
(%). Overweight was defined as a body mass index (BMI; 
weight in kilograms divided by the square of height in meters) 
≥23.0 kg/m2, and obesity was defined as a BMI ≥25.0 kg/m2 
[11]. Abdominal obesity was defined as waist circumference 
≥90 cm in men and ≥85 cm in women. Hypertension was de-
fined as systolic blood pressure (SBP) ≥140 mm Hg or diastol-
ic blood pressure (DBP) ≥90 mm Hg and/or current use of an-
tihypertensive medications. Control of hypertension was de-
fined as SBP and DBP <140/85 mm Hg according to the KDA 
clinical practice guideline for Diabetes 2019 [12]. Hypercho-
lesterolemia was defined as LDL-C ≥100 mg/dL or current use 
of lipid-lowering medication(s), and control of hypercholester-
olemia was defined as LDL-C <100 mg/dL [12,13]. The aware-
ness rate was defined as the rate of people diagnosed with dia-
betes by a doctor among people with diabetes (%). The treat-
ment rate was defined as the rate of people treated with antidi-
abetic drugs among people with diabetes (%). The definitions 
of health behaviors are as follows: current smoking: smoked at 
least five packs of cigarettes (100 cigarettes) during the lifetime; 
high-risk drinking: ≥7 glasses in men or ≥5 glasses in women 
on the same occasion on each of 2 or more days a week; regular 
walking exercise: ≥5 days/week and for ≥30 minutes/activity.
The daily food and energy intake were measured using a sin-
gle day 24-hour dietary recall and semiquantitative food fre-
quency questionnaire method [8]. For estimation of nutrient 
intake, the 2015 Dietary Reference Intake for Koreans was used 
[14]. Excessive energy intake was defined as the condition where-
in the percentage of energy intake was greater than 125% of the 
estimated energy requirement recommended by the Korean 
Dietary Reference Intake [14]. The percentage of energy intake 
from carbohydrate, protein, and fat was calculated using the 
following methods: the percentage of energy intake from carbo-
hydrate=(g of carbohydrate intake×4)/[(g of carbohydrate in-
take×4)+(g of protein intake ×4)]+(g of fat intake×9)]×100; 
the percentage of energy intake from protein=(g of protein in-
take×4)/[(g of protein intake×4)+(g of carbohydrate intake× 
4)+(g of fat intake×9)]×100; the percentage of energy intake 
from fat=(g of fat intake×9)/[(g of fat intake×9)+(g of carbo-
hydrate intake×4)+(g of protein intake×4)]×100.
RESULTS
Prevalence of diabetes and IFG
Table 1 shows the prevalence of diabetes and IFG in 2018. 
Among Korean adults aged ≥30 years in 2018, the prevalence 
of diabetes was 13.8% (4.94 million). The prevalence of diabe-
tes among Korean adults aged ≥65 years was 27.6%. There 
were differences in diabetes prevalence by sex, age group, and 
household income. The prevalence of diabetes in men was 
higher than that in women (15.9% vs. 11.8%). The prevalence 
of diabetes increased with age in both sexes. The prevalence 
exceeded 10% in their forties for men, while for women, it ex-
ceeded 10% in their 50s. In the group aged 40 to 49 years, the 
prevalence of diabetes was 3.7 times higher in men than in 
women (13% vs. 3.5%). However, in individuals aged 70 years 
and older, diabetes was more prevalent in women than in men 
(29.4% vs. 28.8%). By household income quintile, the preva-
lence in the lowest household income quintile was 14.4%, while 
that in the highest quintile was 8.6%.
The prevalence of IFG in Korean adults aged ≥30 years in 
2018 was 26.9% (9.48 million). IFG was more prevalent in men 
than in women (32% vs. 22%).
Current status of managing diabetes
From 2016 to 2018, only 65% of adults with diabetes were 
aware of their condition, and 60.1% were in treatment (oral 
hypoglycemic agent, 56%; insulin therapy, 4.1%) (Table 2). 
Most adults with previously diagnosed diabetes were being 
treated with oral hypoglycemic agents (86.1%), while 6.4% 
were treated with insulin with or without an oral hypoglycemic 
agent; 6.9% were not receiving any treatment for their disease 
(Supplementary Fig. 1). The glycemic control rate among peo-
ple with diabetes was 28.3% for a target goal of HbA1c <6.5% 
(Supplementary Fig. 2). Of people with diabetes, 19.1% had 
HbA1c above 8.0%. According to the target level of the KDA 
treatment guidelines, 28.3% of people with diabetes achieved 
HbA1c <6.5%, 54.4% achieved blood pressure (BP) <140/85 
mm Hg, and 53.3% achieved LDL-C <100 mg/dL.
Jung CH, et al.
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Comorbidities in adults with diabetes and health behaviors
From 2016 to 2018, the prevalence of obesity and abdominal 
obesity in adults with diabetes was 53.2% (50.9% in men and 
56.0% in women) and 54% (50.7% in men and 58.2% in wom-
en), respectively (Fig. 1). When obesity was categorized as class 
I to III, obesity class I (BMI 25.0 to 29.9 kg/m2) accounted for 
41.5% of diabetes, obesity class II (BMI 30.0 to 34.9 kg/m2) ac-
counted for 10.1%, and obesity class III (BMI ≥35 kg/m2) ac-
counted for 1.6%. Morbid obesity of class II and III was 11.7% 
in adults with diabetes. In addition, the estimated prevalence 
and control rate of comorbidities are presented in Table 3. The 
prevalence of hypertension in adults with diabetes was 61.3%. 
Only 54.4% of adults with diabetes were controlled to the target 
Table 1. Estimated prevalence of adults with diabetes and impaired fasting glucose
Variable
Diabetes Impaired fasting glucose
Total Men Women Total Men Women
By age group, yr
   ≥30 13.8 (4,940) 15.9 (2,774) 11.8 (2,166) 26.9 (9,485) 32 (5,535) 22 (3,951)
   ≥65 27.6 (2,044) 27.7 (879) 27.5 (1,165) 29.6 (2,178) 31.6 (993) 28.1 (1,185)
   30–39 3.7 (95) 2.7 (143) 22.9 (410) 11.4 (891)
   40–49 13.0 (148) 3.5 (565) 34 (826) 19.7 (1,474)
   50–59 17.9 (476) 11.3 (760) 39 (1,057) 25.1 (1,656)
   60–69 25.7 (563) 19.0 (720) 31.8 (847) 28.7 (891)
   ≥70 28.8 (883) 29.4 (586) 31 (810) 27.1 (622)
By family income (quintiles)a
   Quintile 1 14.4 16.8 12
   Quintile 2 14 17.1 10.9
   Quintile 3 10.6 11.5 9.6
   Quintile 4 10.6 13.9 7.1
   Quintile 5 8.6 11.7 5.8
Values are presented as percentages (number; thousands). 
aFrom the lowest to the highest.
Table 2. Estimated proportion of awareness, treatment, and 






≥30 yr 65 60.1 28.3
   Men 61.2 56.6 29.2
   Women 69.8 64.6 27.2
≥65 yr 77.9 72.9 29.3
Fig. 1. Estimated proportion of adults with diabetes according to (A) body mass index (kg/m2) and (B) abdominal obesity. Values 
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level of BP. Regarding the prevalence of hypercholesterolemia, 
the prevalence was 72% when based on LDL-C >100 mg/dL or 
antilipidemic agents, and the control rate of hypercholesterol-
emia was 53.5%.
Regarding health behaviors, 21% were current smokers 
(men 34.9% vs. women 3.7%), 23.1% were high-risk drinkers 
(men 30.7% vs. women 6.8%), and 35.7% were walking regu-
larly (men 36.4% vs. women 34.9%) among adults 30 years of 
age with diabetes (Supplementary Table 1).
Prevalence of both hypertension and hypercholesterolemia 
in adults with diabetes
The prevalence of both hypertension and hypercholesterol-
emia was 43.7% (39.4% in men, 49% in women) in adults ≥30 
years of age with diabetes and 51.4% (43.8% in men, 57.2% in 
women) in adults ≥65 years (Table 3). Only 11.5% of subjects 
with diabetes met all three target levels (HbA1c <6.5%, BP 
<140/85 mm Hg, and LDL-C <100 mg/dL).
Dietary intake in adults with diabetes from 2016 to 2018
Total daily energy intake, excess energy intake, and percentage 
of energy intake from macronutrients were evaluated among 
subjects with diabetes, with previously diagnosed diabetes, and 
those without diabetes (Table 4 and Fig. 2). Total energy intake 
and excess energy intake were higher in subjects without dia-
betes than in those with diabetes (total or previously diag-
nosed) (Fig. 2). The percentage of energy intake from carbohy-
drates was high in the diabetes group compared to those with-
out diabetes (68.3% in diabetes, 69.9% in diagnosed diabetes, 
and 64.7% in without diabetes) (Table 4). On the other hand, 
the percentage of energy intake from protein and fat was lower 
in subjects with diabetes than in those without diabetes (for 
protein: 14.5% in diabetes, 14.1% in diagnosed diabetes, and 
15.2% in without diabetes, respectively; for fat: 17.1% in diabe-
tes, 16.0% in diagnosed diabetes, and 20.1% in without diabe-
tes, respectively) (Table 4).
DISCUSSION
In 2018, the prevalence and estimated number of diabetes cas-
es among adults ≥30 years were 13.8% and 4.94 million, re-
spectively. The prevalence of diabetes steadily increased over 
Table 3. Estimated prevalence and control rate of comorbidities in adults with diabetes
Variable
Hypertension Hypercholesterolemia Hypertension and hypercholesterolemia
Prevalence, % Treatment rate, % Prevalence, % Treatment rate, % Prevalence, %
≥30 yr
   Total 61.3 54.4 72 53.3 43.7
   Men 58.9 51.6 67.2 55.3 39.4
   Women 64.4 57.9 77.8 51 49
≥65 yr
   Total 74.3 63.3 68.6 59.5 51.4
   Men 67.3 69.6 63.1 60.6 43.8
   Women 79.7 59.2 72.8 58.8 57.2






















Total 68.3 69.9 64.7 14.5 14.1 15.2 17.1 16.0 20.1
Men 66.5 68.3 63.6 15.2 14.8 15.7 18.3 16.9 20.7
Women 70.6 71.5 65.8 13.8 13.4 14.6 15.7 15.0 19.6
DM, diabetes mellitus.
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17 years from 2001 (8.6%) to 2018 (13.8%) in adults ≥30 years 
of age in a nationally representative sample of Koreans [15-18]. 
HbA1c has been included in the diagnostic criteria for the di-
agnosis of diabetes since KNHANES 2011. More specifically 
HbA1c increased from 12.4% in 2011 to 14.5% in 2013 and 
then decreased slightly to 13.0% and 11.4% in 2014 and 2015, 
respectively [17,19]. Then, it increased again to 14.4% in 2016 
and stayed at approximately 14% [18,20]. In addition, the esti-
mated number of people with diabetes (30 to 79 years) has in-
creased by 54% during the past 8 years, from 3.20 million in 
2010 to 4.94 million in 2018 [18,21].
The global age-standardized diabetes prevalence has grown 
from 4.7% in 1980 to 8.5% in 2014, and this rise in prevalence 
has been compounded by population growth, aging, and in-
creasing overweight or obesity, nearly quadrupling the number 
of adults with diabetes over these 35 years [3]. In the IDF Atlas, 
the global prevalence of diabetes in adults aged 20 to 79 years 
representing 138 countries was estimated to be 8.8% in 2017 
and 9.3% in 2019 and is predicted to rise to 10.9% in 2045 [1]. 
Although it is difficult to fully compare differences in diabetes 
prevalence worldwide due to different data sources, study sam-
ple sizes, ages of the study population, and heterogeneity of 
definitions of diabetes, it is clear that the prevalence of diabetes 
has been steadily increasing for the past 3 decades globally.
Prevalence can be affected by the mortality and incidence of 
diabetes [22]. The prevalence can rise by improving the surviv-
al of people with diabetes and aging but can also decrease by 
decreasing or stabilizing the incidence. In Korea, the preva-
lence of diabetes has mainly increased due to population aging 
and increasing obesity [23,24]. Recently, in terms of incidence, 
some countries, including Korea, have shown decreasing or 
stable incidences of diabetes for several possible reasons [22]. 
It might be starting to benefit from prevention activities of type 
2 diabetes mellitus (T2DM) and reductions in the pool of un-
diagnosed diabetes through increased uptake of the national 
health screening program. Based on the reported DFS thus far, 
the trend of prevalence during the past 7 years in Korea ap-
pears stable at a high rather than substantial rise.
Consistent with the results of previous DFS 2016 and 2018, 
DFS 2020 also showed that the prevalence of diabetes in-
creased with age in both sexes [18-20]. The prevalence of dia-
betes over the age of 65 was 27.6%, which was twice the preva-
lence of diabetes over the age of 30 (13.8%). Consistent with 
previous DFS and other countries, the prevalence of diabetes 
showed variations according to sex; that is, it was higher 
among men than women [18,19,25]. DFS 2020 also showed 
that lower family income level was associated with higher 
prevalence of diabetes in both sexes. The burden of diabetes 
has increased at a greater rate in low- and middle-income 
countries than in high-income countries globally [3].
In addition, the prevalence and estimated number of IFGs 
were 26.9% and 9.48 million in adults aged ≥30 years and 
29.6% and 2.17 million in adults aged ≥65 years, respectively. 
The estimated number of IFGs in this group was already 1.3 
million. The prevalence of IFG gradually increased from 24.8% 
in DFS 2016 to 25.3% in DFS 2018 and to 26.9% in DFS 2020. 
We investigated the distribution of IFG prevalence according 
to sex and age. A higher prevalence of IFG was observed in 
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men than in women at all ages. A drastic increase in the preva-
lence of IFG was observed among men aged 30 and 40 years 
and then decreased among elderly individuals above 60 years, 
whereas the prevalence among women showed a continuous 
increase with age. The estimated number of IFGs was reversed 
in both men and women for the elderly population aged above 
70 years. Prevalence estimates of IFG reported in the literature 
vary greatly due to the diagnostic criteria used, the screening 
test, and characteristics of the study population [26-28]. A 
large meta-analysis of studies that reported prevalences in 
Caucasian and Asian cohorts estimated the IFG prevalence to 
be 53.1% [27]. In another meta-analysis, the mean overall 
prevalence of IFG in Europe was 8.4% (7.1 to 9.9) [28]. The 
prevalence of IFG is clearly increasing rapidly in all parts of the 
world. Because of the increasing risks of T2DM and cardiovas-
cular disease (CVD) in prediabetic (IFG, impaired glucose tol-
erance) subjects and the possible reversibility of IFG, contrary 
to the irreversibility of diabetes, IFG has received increasingly 
widespread attention [29]. For the young age group, long-term 
exposure to IFG risks can lead to the early development of dia-
betes and vascular complications. Therefore, early identifica-
tion of people with IFG and preventive lifestyle modifications 
should be strongly recommended.
Early intensive and continuous glucose control in people 
with diabetes can delay progression to microvascular and mac-
rovascular complications. However, the effectiveness of these 
interventions at the population level has been unsatisfactory 
because considerable people with diabetes remain undiag-
nosed, and adherence to treatment may be low in the general 
population. In this study, the awareness and treatment of dia-
betes were 65% and 60.5%, respectively. Despite the improve-
ments in screening and health promotion, 35% of the people 
with diabetes were unaware of their condition. In addition, 
39.5% did not take treatment with glucose-lowering agents or 
modify their lifestyle. Nonetheless, the awareness and treat-
ment proportion in this study were higher than those found in 
2013 to 2016 (62.5% and 56.7%, respectively) and those found 
in China and Switzerland [18,30,31].
Regarding glycemic control, the rate of good glycemic con-
trol (HbA1c <6.5%) in people with diabetes rose steadily from 
24.8% in 2013–2014 to 25.1% in 2013–2016 to 28.3% in 2016–
2018 [18,19]. The control rates of HbA1c <7.0% were 43.3%, 
52.6%, and 56.9% in 2013–2014, 2013–2016, and 2016–2018, 
respectively [18,19]. In particular, the poor control rate (de-
fined as HbA1c ≥9.0%) decreased steadily from 15.5% in 
2013–2014 to 10.8% in 2013–2016 to 9.6% in 2016–2018 [18, 
19]. Although the rate of good glycemic control of HbA1c 
<6.5% has increased steadily over the past 7 years, it is still as 
low as 30%.
Regarding health behaviors, the rate of current smoking de-
creased from 27.4% in DFS 2016 to 24.1% in DFS 2018 and to 
21.1% in DFS 2020, but the rate of high-risk alcohol drinking 
increased from 21.9% in DFS 2016 to 23.1% in DFS 2020. The 
rate of regular walking did not improve (37.9% in DFS 2016, 
36.0% in DFS 2018, and 35.7% in DFS 2020). Large reductions 
in smoking rates occurred in the 1970s and 1980s, followed by 
gradual reductions thereafter [32]. Korea is no exception. Ac-
cording to the study by Park [33] investigating adherence to 
dietary recommendations between diagnosed and undiag-
nosed subjects with T2DM using 1998 to 2012 KNHANES, 
adherence to moderate alcohol drinking habits decreased over 
time, as was observed in the current DFS. In the present study, 
high-risk drinking was defined as ≥7 drinks/day in men, ≥5 
drinks/day in women, and 2 times/week, whereas moderate al-
cohol consumption was defined as ≤1–2 drinks/day in Park’s 
study [33]. Although the definition of alcohol consumption 
was not identical between the two studies, the two studies all 
indicated decreasing trends in healthy alcohol consumption 
habits.
Adults with diabetes continue to have a two to three times 
higher rates of CVD than adults without diabetes [34]. An in-
creased prevalence of the comorbid conditions obesity, hyper-
tension, and dyslipidemia, along with poor rates of glucose 
control, may potentiate CVD risk. Therefore, intense efforts for 
the prevention and proper management of diabetes and co-
morbid diseases are required.
The prevalence of obesity steadily increased from 44.4% in 
2011 to 48.6% in 2013–2014 to 50.4% in 2013–2016 and to 
53.2% in 2016–2018 [18,19,24]. The rate of normal BMI was 
only 23.3% in this study. There has been little success in pre-
venting and combating obesity despite global efforts and cam-
paigns.
The prevalence of hypertension in diabetes increased (54.6% 
in 2011, 54.7% in 2013–2014, 55.3% in 2013–2016, and 61.3% 
in 2016–2018). However, the control rate of hypertension was 
improved compared to KNHANES in 2011 (25.2% in new 
DM, 39.9% in known DM), whereas it showed no improve-
ment thereafter (69.1% in 2013–2014, 68.4% in 2013–2016, 
and 67.9% in 2016–2018) [35]. The prevalence of hypercholes-
terolemia in this study was much higher than that of previous 
Jung CH, et al.
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reports (72% vs. 31.6% in 2013–2014 and 34.9% in 2013–
2016). This was largely caused by differences in the definition 
of hypercholesterolemia. Previous DFS defined hypercholes-
terolemia based on TC ≥240 mg/dL, whereas DFS 2020 de-
fined hypercholesterolemia as LDL-C ≥100 mg/dL. In this 
study, when it was defined based on TC ≥240 mg/dL, the 
prevalence was 42.4% (37.1% in men, 49.1% in women, data 
not shown). Therefore, we cannot directly compare the differ-
ences in the prevalence of hypercholesterolemia between stud-
ies. The control rate of hypercholesterolemia as LDL-C <100 
mg/dL increased somewhat from 49.8% in 2013–2016 to 
55.3% in this study. In addition, nearly half of people with dia-
betes had both hypertension and hypercholesterolemia (43.7% 
in adults ≥30 years and 51.4% in adults ≥65 years).
The comprehensive management of diabetes through 
achievement of ABC clinical targets (A, HbA1c <6.5%; B, BP 
<140/85 mm Hg; C, LDL-C <100 mg/dL) is important to pre-
vent and delay vascular complications. However, only 11.5% of 
subjects achieved all three ABC targets in this study. Although 
all target achievement rates were still low, they showed increas-
ing trends (9.4% in 2013–2014, 8.4% in 2013–2016, and 11.5% 
in 2016–2018).
In the present fact sheet, we investigated the total energy in-
take, excess energy intake, and percentage of energy intake 
from each macronutrient among people with diabetes, with 
previously diagnosed diabetes, and those without diabetes. 
Less energy, protein, and fat intake and more carbohydrate in-
take were shown in people with diabetes than in people with-
out diabetes. Although there is no ideal percentage of macro-
nutrients or eating patterns that can apply to all people with di-
abetes, low carbohydrate and lower caloric intake have been a 
focus in diabetes [36]. In particular, Koreans traditionally have 
a high carbohydrate eating pattern; therefore, they have been 
recommended to eat fewer carbohydrates [37]. Relatively, 
modification of protein intake has been less of a focus, al-
though low protein intake in Korea has been previously re-
ported [37]. Regarding fat, people with diabetes may have a 
tendency and make an effort to eat less fat to control diabetes-
associated comorbidities, such as obesity and hypercholester-
olemia. Lee et al. [37] evaluated food patterns of a high-carbo-
hydrate diet among the Korean general population aged ≥20 
years using data from the 2013 to 2015 KNHANES. Fifty-eight 
percent of men and 60% of women exceeded the recommend-
ed range of carbohydrate intake. A higher carbohydrate diet 
was associated with intake of low energy and saturated fats, 
with more grains and fruit but little consumption of protein-
containing foods, such as meat, fish, eggs, beans, and milk. En-
ergy intake decreased across the carbohydrate groups. They 
found a positive association of dietary carbohydrates with 
metabolic disease. Our study showed that higher carbohydrate 
intake and lower energy intake were observed in the diabetes 
group than in the non-diabetes group irrespective of diag-
nosed or undiagnosed diabetes. Regarding the lower energy 
intake in the diabetes group, underreporting food intake has 
been suggested as a problem in diabetic patients [38]. Park [33] 
investigated the levels of adherence to dietary recommenda-
tions between diagnosed and undiagnosed subjects with 
T2DM in Korea from 1998 to 2012 KNHANES. The overall 
adherence levels to dietary recommendations were low regard-
less of awareness of disease. One of the least followed recom-
mendations was moderating carbohydrate consumption. Both 
diagnosed and undiagnosed T2DM subjects had a low level of 
adherence in limiting carbohydrate consumption to 50% to 
60% of total energy intake, with only 10% to 20% of subjects 
following this guideline. Carbohydrate intake is higher in the 
Korean population than in other Asian and Western popula-
tions [39,40]. However, another recent report demonstrated 
that the food sources of energy intake are changing [41]. None-
theless, carbohydrate intake is still high in Korea. Because 
there were several limitations to assessing the nutritional pat-
terns of Korean people with diabetes, the data should be inter-
preted with caution. First, because the study design was cross-
sectional, we do not know whether the pattern in subjects’ di-
ets would contribute to the development of their disease or has 
been changed because of their diseases. In addition, the 1-day 
24-hour recall report may not reflect the usual dietary intake 
of the people, and the retrospective assessment of dietary in-
take may induce some measurement errors. Further longitudi-
nal studies are necessary to understand why diabetic patients 
showed higher carbohydrate and less energy intake than their 
nondiabetic counterparts.
In conclusion, a stable high prevalence of diabetes, a steadily 
increasing prevalence of IFG, and a low glycemic control rate 
in people with diabetes were again confirmed. In addition, 
nearly half of people with diabetes had both hypertension and 
hypercholesterolemia, and the target achievement rate was still 
very low. Therefore, more stringent efforts are needed to pre-
vent the development of diabetes and improve the comprehen-
sive management of diabetes to reduce diabetes-related mor-
bidity and mortality.
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Supplementary Table 1. Estimated proportion of health behaviors in adults with diabetes
Variable Current smoking, % High-risk drinking, % Regular walking exercise, %
≥30 yr
   Total 21.1 23.1 35.7
   Men 34.9 30.7 36.4
   Women 3.7 6.8 34.9
≥65 yr
   Total 9.8 9 32.5
   Men 20 13.4 38.2
   Women 1.8 2.2 28.2
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 Oral hypoglycemic agent only
 Insulin±Oral hypoglycemic agent
 No treatment
 Lifestyle modification only
Supplementary Fig. 1. Estimated proportion of adults with diabetes according to type of treatment for hyperglycemia. (A) Total 
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